Wegovy Headaches: Clinical Data, Causes & How to Keep Them Under Control
Yes, Wegovy can cause headaches, but only a little more often than a placebo does. In clinical trials of Wegovy (semaglutide), 14% of adults had headaches, compared with 10% on placebo (Wegovy prescribing information), and the main weight-loss trial found much the same: 15.2% vs 12.2% (Wilding et al., NEJM 2021). Glapp, the GLP-1 tracker, lets you log each headache right next to your Wegovy doses, so you can tell whether yours really follow your shot.
Key numbers
| Number | What it means |
|---|---|
| 14% | of adults on Wegovy had headaches in its weight-loss trials, vs 10% on placebo |
| 6,128 | users currently tracking Wegovy-related headaches in Glapp |
Wegovy headaches: what the clinical evidence shows
Wegovy's prescribing information pools placebo-controlled weight-loss trials of semaglutide 2.4 mg in adults. Headache and related symptoms:
| Side effect | Placebo | Wegovy 2.4 mg |
|---|---|---|
| Headache | 10% | 14% |
| Dizziness | 4% | 8% |
| Fatigue | 5% | 11% |
Source: Wegovy prescribing information, Table 3.
STEP 1 (1,961 adults, 68 weeks) found a similar gap: 15.2% on semaglutide 2.4 mg vs 12.2% on placebo (Wilding et al., NEJM 2021).
Why does Wegovy cause headaches?
The prescribing information for this GLP-1 weight loss medication doesn't give one cause. The most likely triggers come with how semaglutide works: eating much less, skipping meals on low-appetite days, and losing fluids through nausea, vomiting or diarrhea. Not drinking enough is one of the most common headache triggers in general.
Caffeine, sleep and screen time play a part too, and they're different for everyone. Your Glapp check-ins show which ones line up with your headache days.
Dehydration, skipped meals and caffeine: the usual suspects
Most headaches on Wegovy trace back to a few everyday triggers:
- Dehydration. Drinking less as your appetite drops, or losing fluids through nausea or diarrhea, is the most common one.
- Long gaps without food. Going many hours without eating can bring on a headache for some people.
- Caffeine changes. If you've cut back on coffee or energy drinks along with food, a withdrawal headache can follow for a few days.
- Lower blood pressure. Blood pressure often falls as you lose weight, especially if you take blood pressure medicine, and that can feel like a dull headache or lightheadedness.
Track your Wegovy headaches with a GLP-1 tracker app
A headache could be Wegovy, or the coffee you skipped. A GLP-1 tracker helps you tell the difference: log each headache next to your Wegovy doses, and you're in control. You'll know which days after your shot they come, how strong they are and whether they're easing, and you'll walk into your next appointment with facts instead of guesses.
Why Glapp? It's a top-rated GLP-1 tracker used by 100,000+ people, rated 4.8/5 on Trustpilot and the App Store, and 4.6/5 on Google Play. Glapp grew out of Reddit GLP-1 support groups and is built by developers who are GLP-1 users themselves, so most features come straight from community requests. Its features are grounded in peer-reviewed research and published clinical trial data, core tracking is free, and it works on iPhone, Android and web with your data synced across devices. Here's how to use it over your first 30 days.
Glapp does not provide medical advice or treat side effects. It shows your daily check-ins against your estimated medication levels so you have structured data to share with your prescriber.
Day 1: Start tracking your headaches
Use Glapp's daily check-in to record each headache and rate how severe it feels.
Daily entries help you see whether your headaches are getting better, getting worse or staying the same. You'll have a clear record of how you felt, without having to remember every day.
Day 3: Compare symptoms with your estimated Wegovy level
Glapp estimates your medication level throughout the day using your dose and injection time. Semaglutide typically reaches its highest blood concentration 1–3 days after an injection.
Seeing your symptoms alongside this estimate helps you spot when headaches appear within your shot cycle. As you log more days, you can look for a repeating pattern and know when to pay closer attention.
The medication level is an estimate, not a blood test, and a matching pattern does not prove what caused your symptoms.
Day 7: See how your headaches change over time
Open the side-effects chart in the Progress tab and choose the period you want to review. Your daily ratings appear on a timeline, making it easier to see whether a difficult day was an isolated episode or part of a longer trend.
Day 14: Look for patterns in your weekly report
Glapp's weekly progress report brings your logged data together, with dedicated sections showing your side effects and how they change.
Do your headaches tend to return on the same day after your shot? Do they coincide with changes in hunger or food noise? Reviewing two weeks of entries can help you spot patterns that are easy to miss day by day, and give you specific questions to discuss with your doctor.
Day 30: Bring a clear record to your doctor
After a month, review the bigger picture: are your headaches becoming less frequent, staying the same or getting worse? Semaglutide generally reaches a steady repeating level after about four to five weeks of weekly injections at the same dose.
Create a doctor's report in Glapp and choose the information to include. Your doctor can review your symptom history alongside your doses and progress, giving you a more focused conversation about your treatment.
Start tracking your Wegovy headaches in Glapp
Wegovy headaches and dose increases: from 0.25 mg to 2.4 mg
Wegovy starts at 0.25 mg once weekly and steps up every four weeks: 0.5 mg, 1 mg, 1.7 mg, then 2.4 mg maintenance from week 17. Wegovy's prescribing information also allows a higher 7.2 mg dose for some adults. The semaglutide trial figure for headache is at 2.4 mg and isn't broken down by step.
Your weekly progress report shows whether headaches changed after a step.
See every dose in the Wegovy dosage chart.
What to bring to your prescriber
A simple log shows your prescriber the pattern at a glance:
| Week | Dose | Headache days | Strongest day after shot | Peak rating | Other side effects logged |
|---|---|---|---|---|---|
| Example 1 | 0.5 mg | 3 | Day 2 | Med | Nausea |
| Example 2 | 0.5 mg | 3 | Day 2 | Med | Dizziness |
| Example 3 | 0.5 mg | 2 | Day 1 | Low | None |
| Example 4 | 0.5 mg | 1 | Day 2 | Low | None |
Questions you could ask. They're conversation starters, not recommendations; your prescriber decides what, if anything, to change.
- "My headaches come on the same days as my nausea. Could they be linked?"
- "Which pain reliever is OK to take with Wegovy?"
- "Should my headaches change how we plan my next dose step?"
A sudden, severe headache, or one with vision changes, confusion or weakness, needs urgent care.
Frequently asked questions
Is headache a side effect of Wegovy?
Yes. 14% of adults on Wegovy 2.4 mg had headaches in the weight-loss trials, compared with 10% on placebo.
How long do Wegovy headaches last?
Most headaches linked to starting Wegovy are short-lived. They tend to ease as you settle on a dose and keep up with fluids and regular eating, and caffeine-withdrawal headaches usually pass within a few days. If they keep coming after several weeks, or feel different from your usual headaches, talk to your prescriber.
Does Wegovy cause dizziness?
Yes, dizziness was reported by 8% of adults on Wegovy vs 4% on placebo.
How do I track Wegovy headaches?
Log them in Glapp's daily check-in and rate them low, medium or high. Glapp shows each rating next to your estimated medication level, so you can see whether they follow your shot.
About the data
Ratings are self-reported and medication levels are estimated from dose and timing, not measured. This page is for information only and is not medical advice; talk to your prescriber about any side effect.
About the author
We're GLP-1 patients and health tech professionals, building Glapp in collaboration with doctors. About us
Sources
- Novo Nordisk. Wegovy (semaglutide) injection prescribing information: Table 3, dosage (section 2), pharmacokinetics.
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM, 2021.